Literature DB >> 19442604

Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Robert W Cowan1, Isabella W Y Mak, Nigel Colterjohn, Gurmit Singh, Michelle Ghert.   

Abstract

The characteristic bone destruction in giant cell tumour of bone (GCT) is largely attributed to the osteoclast-like giant cells. However, experimental analyses of bone resorption by cells from GCT often fail to exclude the neoplastic spindle-like stromal cells, and several studies have demonstrated that bone resorption by GCT cells is increased in the presence of stromal cells. The spindle-like stromal cells from GCT may therefore actively contribute to the bone resorption observed in the tumour. Type I collagen, a major organic constituent of bone, is effectively degraded by three matrix metalloproteinases (MMPs) known as the collagenases: MMP-1, MMP-8 and MMP-13. We established primary cell cultures from nine patients with GCT and the stromal cell populations were isolated in culture. The production of collagenases by primary cultures of GCT stromal cells was determined through real-time PCR, western blot analysis and a multiplex assay system. Results show that the cells produce MMP-1 and MMP-13 but not MMP-8. Immunohistochemistry confirmed the presence of MMP-1 and MMP-13 in paraffin-embedded GCT tissue samples. Medium conditioned by the stromal cell cultures was capable of proteolytic activity as determined by MMP-1 and MMP-13-specific standardized enzyme activity assays. The spindle-like stromal cells from GCT may therefore actively participate in the bone destruction that is characteristic of the tumour.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442604      PMCID: PMC2894938          DOI: 10.1016/j.bone.2009.01.393

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  55 in total

1.  Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.

Authors:  J Wen; D Xie; J Yao; M Zhang; J Bi
Journal:  Chin Med J (Engl)       Date:  1999-05       Impact factor: 2.628

2.  Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.

Authors:  Yu Sin Lau; Afsaneh Sabokbar; C L M H Gibbons; Henk Giele; Nicholas Athanasou
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

3.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Properties of the stromal cell in giant cell tumor of bone.

Authors:  Michelle Ghert; Nicole Simunovic; Robert W Cowan; Nigel Colterjohn; Gurmit Singh
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

5.  Osteoblast lineage properties in giant cell tumors of bone.

Authors:  Atsushi Murata; Takuya Fujita; Norio Kawahara; Hiroyuki Tsuchiya; Katsuro Tomita
Journal:  J Orthop Sci       Date:  2005-11       Impact factor: 1.601

6.  Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.

Authors:  N Miyamoto; Y Higuchi; M Tajima; M Ito; M Tsurudome; M Nishio; M Kawano; A Sudo; A Uchida; Y Ito
Journal:  J Orthop Res       Date:  2000-07       Impact factor: 3.494

7.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

8.  Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.

Authors:  Ted S Liao; Matthew B Yurgelun; Seong-Sil Chang; Hui-Zhu Zhang; Koko Murakami; Theodore A Blaine; May V Parisien; William Kim; Robert J Winchester; Francis Young-In Lee
Journal:  J Orthop Res       Date:  2005-01       Impact factor: 3.494

9.  MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1.

Authors:  Scott L Kominsky; Michele Doucet; Margaret Thorpe; Kristy L Weber
Journal:  Clin Exp Metastasis       Date:  2008-08-16       Impact factor: 5.150

10.  Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects.

Authors:  Yong Pei; Anita Harvey; Xiao-Peng Yu; Srinivasan Chandrasekhar; Kannan Thirunavukkarasu
Journal:  Osteoarthritis Cartilage       Date:  2006-03-20       Impact factor: 6.576

View more
  8 in total

1.  Chondroclasts are mature osteoclasts which are capable of cartilage matrix resorption.

Authors:  H J Knowles; L Moskovsky; M S Thompson; J Grunhen; X Cheng; T G Kashima; N A Athanasou
Journal:  Virchows Arch       Date:  2012-07-11       Impact factor: 4.064

2.  Evaluation of the multiple tissue factors in bone of primary osteoplasty and rhinoplasty in patients affected by cleft lip palate.

Authors:  Dace Buile; Māra Pilmane; Ilze Akota
Journal:  Histol Histopathol       Date:  2022-03-18       Impact factor: 2.130

3.  Titanium particles up-regulate the activity of matrix metalloproteinase-2 in human synovial cells.

Authors:  Chunfeng Fu; Jing Xie; Ning Hu; Xi Liang; Rongfu Chen; Chunli Wang; Cheng Chen; Chunming Xu; Wei Huang; K-L Paul Sung
Journal:  Int Orthop       Date:  2013-11-24       Impact factor: 3.075

4.  AP-1 as a Regulator of MMP-13 in the Stromal Cell of Giant Cell Tumor of Bone.

Authors:  Isabella W Y Mak; Robert E Turcotte; Snezana Popovic; Gurmit Singh; Michelle Ghert
Journal:  Biochem Res Int       Date:  2011-02-27

5.  PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis.

Authors:  Isabella W Y Mak; Robert W Cowan; Robert E Turcotte; Gurmit Singh; Michelle Ghert
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

6.  An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.

Authors:  Manisha Shah; Dexing Huang; Tony Blick; Andrea Connor; Lawrence A Reiter; Joel R Hardink; Conor C Lynch; Mark Waltham; Erik W Thompson
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

7.  Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone.

Authors:  Alexander Rabinovich; Isabella W Y Mak; Robert W Cowan; Robert E Turcotte; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Open Bone J       Date:  2009

8.  Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production.

Authors:  Barun Poudel; DO-Kuk Kim; Hyeon-Hui Ki; Young-Bae Kwon; Young-Mi Lee; Dae-Ki Kim
Journal:  Oncol Lett       Date:  2013-11-04       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.